Marc H V Van Regenmortel obtained his PhD at the University of Cape Town Medical School in 1961 and was in 1965-1966 an International Fellow in the US Public Health Service at the University of California in Berkeley. Subsequently he was a professor in Virology / Microbiology at several Universities in South Africa and France and , for 22 years , he directed the Immunochemistry Laboratory at the University of Strasbourg in the CNRS Molecular Biology Institute . In 2001 he became an Emeritus CNRS Research Director in Strasbourg He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He was for ten years a member of the international advisory board of the South African Aids Vaccine Initiative (SAAVI) and of the Institute of Microbiology and Molecular Medicine at the University of Cape Town. In 1995-2005 , he was a member of the board of directors of the biosensor company BIACORE in Uppsala , Sweden He has supervised the research work of 30 PhD students and published 400 research and review papers as well as a dozen books in the fields of Virology and Immunochemistry. He is currently Editor-in-Chief of Journal of Molecular Recognition and previously of Archives of Virology and Journal of AIDS & Clinical Research. He is also an Associate Editor of Advances in Virus Research, Analytical Biochemistry, Frontiers in Immunology, Journal of Immunological Methods and Bionomina. In 2008 , he co- edited with Brian Mahy of the CDC, the 3rd edition of the Encyclopedia of Virology in five volumes published by Elsevier. His h-index is 51.
Senior Investigator, National Cancer Institute, National Institute of Health. (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)HTLV-1 causes cancer and neuropathology, whereas HIV causes AIDS. We uncovered the mechanisms used by HTLV-1 to inhibit innate and adaptive host responses and that HTLV-1 replication in vivo depends on infection of monocytes that necessitate cleavage of the viral p12 precursor protein, thus providing a novel viral therapeutic target. We engineered vaccines, together with the private sector, to prevent HTLV-1 and HIV infection. One of the HIV vaccines, the ALVAC-HIV/gp120, has been the first to demonstrate limited, but significant protection against HIV acquisition in humans. Our studies in macaques mirror the human results thereby providing the opportunity to identify the immunological effector(s) of protection and improve vaccine efficacy against HIV. We found that RAS activation correlates with protection against SIV, suggesting that triggering RAS may improve vaccine induced protection. Thus, the focus of my lab in the next years will be to identify molecules that by activating RAS may function ads adjuvants for an HIV vaccine candidate. Areas of Expertise: 1. Molecular retrovirology 2. Vaccinology 3. Immunology 4. Retroviral pathogenesis Over the years I have had extensive collaborations with Academic Institutions, Government agencies and the Private Corporate Sector. The NCI and other NIH institutes have provided a fantastic environment for pursuing my scientific goals. Some of the work that I have done here could not be done as efficiently everywhere else because of its risky nature and broadness of its scope. My laboratory has been very productive over the years and we had outstanding ratings at several reviews of the intramural program. I am grateful to the talented and dedicated post-docs that trained with me and made and still make this possible.
Thobile N. Khanyile is a Medical Intern Scientist at Inkosi Albert Luthuli Central Hospital (NHLS), where she is training to be a qualified Medical Scientist and register with HPCSA. The program started in March, 2018 and will end in March, 2020. I am currently due to finish my Masters in Medical Microbiology at University of KwaZulu Natal (UKZN). I studied Medical Science (Physiology) degree and did my postgrad degree (Honors) in Medical Microbiology at UKZN, 2012 and 2013, respectively. I started my Masters degree (Medical Microbiology) in 2016, my focus is on the STIs (mainly Chlamydia trachomatis) since they are the burden in health department as they also enhance HIV/AIDS transmission and causes other serious sequelae. I have attended FIDSSA 2017 conference to do poster presentation in Cape Town. I have worked as a Medical Research Assistant for a period of one year, where I was involved in different studies that were running in the laboratory (IACH-NHLS) and trained in diagnostic laboratory. I got to work with different professions that are experience in the laboratory and became fluent with the laboratory procedures. Joining NHLS will make me accomplish my dream of becoming a qualified scientist and involve myself in both diagnostic and research work. I believe in working hard and following your dreams no matter what the circumstances. My dream is to have good impact and inspire young individuals.
Prof. Dr. Ram Sharan Mehta is Head of Medical-Surgical Nursing Department in College of Nursing, B. P. Koirala Institute of Health Sciences Nepal. I am involved in teaching Medical-Surgical Nursing for more than 20 years. I am involved in teaching the Nursing Education to the undergraduate and post graduate nursing students. I am the research committee member of this institute and actively involved in the guiding the undergraduate and post graduate nursing students.
Alok Hemal professor, department of pediatrician pgimer, dr. Ram Manohar Lohia Hospital New Delhi present affiliation Pgimer Dr. Ram Manohar Lohia Hospital New Delhi Major Achievements: (honours) (awards)(publications)special interest in Hemato-oncology & pediatric hiv. He is national convenor pediatric HIV Indian Academy of Pediatrics. He has certificate of completion of specialist training from Royal College of Pediatric & Child Health (RCPCH), London Uk. He has more then 50 research publications in national & international journals. Furthermore, he has many presentations in national & international conferences.
Foster, Antonina is a dedicated nurse practitioner with stellar academic and clinical experience. Meticulous researcher passionate about improving the health and well-being of women and children. Superior communicator with outstanding customer service abilities in complex and time-sensitive situations. Certifications include: • Certificate of Completion, Research Coordinator Training Program, 2008 • Diabetes Educator, National Certification Board of Diabetes Educators, 2004 • Advanced Life Support, American Heart Association, 2002 • Women’s Health Care Nurse Practitioner, National Certification Corporation, 2001 • Basic Cardiac Life Support, American Heart Association, 1998 • ASCCP certified colposcopist, 2015 EDUCATION & HONORS EMORY UNIVERSITY, Atlanta, Georgia Doctorate of Nursing Practice ~ Expected Graduation, Fall 2018 UNIVERSITY OF ALABAMA, Birmingham, Alabama Master of Public Health, 2001 ~ Concentration in Maternal Child Health ~ Awarded a Maternal Child Health Traineeship Grant Master of Science in Nursing, 2001 ~ Concentration in Women’s Health ~ Awarded a National Institute of Health Nursing Traineeship Grant TUSKEGEE UNIVERSITY, Tuskegee, Alabama Bachelor of Science in Nursing, 1998 ~ Graduated second out of 20 nursing students ~ Dean’s Lists
His laboratory studies the virology, immunology and therapy of HIV-1 and HBV persistent infection. He currently focus on viral factors that interact and counteract host innate anti-viral immunity, and on how human immune cells are dysregulated and contribute to diseases during HIV-1 and HBV infection. He have developed various mouse models including humanized mouse models with human immune and liver cells to study human immunopathology of chronic HIV-1 and HBV infection in vivo. Regarding HIV-1 infection, He currently focus on the HIV-1/pDC/IFN-I axis that plays a critical role in AIDS progression. He also study HBV virology and the HBV-Macrophage/stellate cell axis in HBV-induced liver diseases. In addition, He is developing novel immune modulatory therapeutics including antibodies, adjuvants and vaccines.
Farzana Rashid has completed her PhD in Molecular Biology from Beijing University of Chemical Technology, China. She has published more than 30 papers in reputed National and International journals and has been serving as an Associate Professor at Lahore College for Women University, Lahore. Supervised about 45 MS and BS students. Currently teaching & supervising BS, MS and PhD students
I hold a master’s degree in medical virology obtained from the University of Kwa-Zulu-Natal; Durban, South Africa in 2017. Curently, I work for the department of virology, university of the Witwatersrand, Johannesburg; South Africa as a Research Associate. The department of virology at the university of the Witwatersrand is still on its inception, only started in September 2016. My duties includes leading research agenda within the department. This includes expanding on interrogating HIV drug resistance, through studying vulnerable population, including those individuals who are experiencing viral co-infections with HIV. In my previous job, I have worked extensively on HIV surveillance and drug resistance in a rural South African setting. This included involvement in running HIV drug resistance testing using both Sanger and next generation sequencing (NGS), as well as analysing the sequences thereafter. My master’s project/dissertation was on HIV minority variants from the paediatrics rural cohort who were failing anti-retroviral therapy (ART). Given that South Africa has limited number of available regimens, there is greater need of maintaining patients on regimens they are currently using for longer, in order to achieve better patient management. Therefore, a need for detecting and quantifying the prevalence of HIV drug resistant mutations including those bearing minority variants in patients especially paediatric cohort. In particular, among children because this is the only population that would require ART for lifetime.
Will be updated soon...
Bernard’s an MSM from the LGBTI community Uganda, personsaffected by punitive laws, regulations and policies, severely stigmatized and marginalized, and are disproportionately affected by HIV,This includes men who have sex with men (MSM), transgender persons (TG), sex workers (SW) and their Children and people who inject drugs (PWID) and other underserved communities., August 2009 Nominated Volunteer by Uganda Red Cross Society Management to support Office of the Secretary General in preparation of meetings with confidential and sensitive clerical services for Partnerships, Management, Governing Board and National Council meetings which exposed me to decision making skills and preparation of such big meetings for an organization,2009-2010 achieved a Diploma in Social Development from Nsamizi Institute of Social Development. He has spent all his education semesters in Uganda where his research allowed him to offer services to all without discrimination.20th February – 20th May 2010 Volunteer Internship with Reproductive Health Uganda (RHU)Peer Educator. After graduation, Benard focused on advocating for the rights of the young people with emphasis on access to Sexual and Reproductive Health and Rightsfriendly services without discrimination. He joined the LGBTI community Movement in 2012 under Spectrum Uganda an MSM organization for 3 years of volunteer services, laterestablished Vijana Na Children Foundation (Vinacef)Uganda with the main focus on Integrated Community Based Sexual and Reproductive Health and Rights for Youth Development Programmes in Uganda and he is the Secretary General,Benrad is has also had several trainingsMarch 2013, Underwent a Peer Educators Training on Key Population Health Conditions at Most at Risk Populations Initiative (MAPI), MulagoHospital, August 2011, Underwent Child Protection Policy organized by Watoto Church,1st – 17th December 2010, trained in Interpersonal Communication for Reproductive Health organized by Programme for Accessible Health Communication and Education (PACE).27th November to 3rd December 2009, trained in Practical Commercial Skills Youth Camp Training, organized by Uganda Red Cross Society in Entebbe Branch,4th – 11th June 2008, Participated in Community Based Standard First Aid Training Course conducted by Uganda Red Cross Society, Kampala East Branch,1st – 8th August 2006, Training in Basic Theory and Practical First Aid Training Workshop conducted by Uganda Red Cross Society, West Branch
With a career long dedicated to HIV patient care and clinical research, Dr Corklin
(Corky) Steinhart enhances his role at ViiV Healthcare with more than 25 years of
HIV experience. Having founded a multi-physician practice focused on specialty
care for those living with HIV, Corky’s expansive HIV knowledge and solid clinical
skills complement his leadership role in responding to ViiV’s global medical and
scientific needs, and he and his team of medical experts provide critical input into
attaining ViiV’s goals of HIV innovation and treatment access.
Current Role: Corky is currently Head of ViiV’s Global Medical Directors team, where he directs a team of ViiV experts in providing worldwide scientific and medical expertise and governance for ViiV initiatives. This includes oversight of the team’s involvement in ViiV-sponsored clinical trials, investigator-sponsored research opportunities, patient access programs, and medical and safety topics.
Experience: Prior to his current role with ViiV, Corky served since 2013 as ViiV’s Global Medical Lead for Triumeq, a single tablet HIV therapy. Before that, he held a number of Medical Affairs positions in the HIV and hepatitis C therapeutic areas for seven years at Merck. Before joining industry, Corky founded Steinhart Medical Associates in 1991 in Miami, Florida as a medical practice specializing in HIV care. By the time Corky left the practice in 2006, he was caring for more than 750 HIV positive patients and the practice had expanded to include four physicians providing care to a total of more than 2300 HIV positive patients. During his time at Steinhart Medical Associates, Corky also founded and served as Medical Director of Special Immunology Services at Mercy Hospital in Miami, FL, and served as Chairperson of the hospital’s Institutional Review Board. In addition, he was Medical Director of the Florida Caribbean AIDS Education Training Center. Over the years, Corky has conducted numerous HIV studies, served on multiple pharmaceutical advisory boards, lectured both nationally and internationally, and published extensively.Education: Corky earned his MD degree in 1986 from the University of South Florida College of Medicine in Tampa, and a PhD in Cardiovascular Physiology in 1981 from Johns Hopkins University. He completed his postgraduate training at the University of Miami Jackson Memorial Hospital.
Dr. De received PhD from University of Maryland, USA. Completed two postdoctoral studies at Cornell and Vanderbilt university. Professor De is currently the Division Chief of Clinical Chemistry and POCT laboratories. Published more than 68 peer reviewed articles and meeting abstracts. Received research grants from national and local agencies. Reviewer of national and international journals. Honored with Paul Finley Chemist Award. Served in American Board of Clinical Chemistry, Toxicology and Molecular Pathology. He was elected to be the chair of nominating committee of this board in 2016. Dr. De is the president elect, Rocky Mountain Division of American Association of Clinical Chemistry.
Hana Zelenková has been active in the field of Dermatovenerology since 1973. Since 2000 she has been directing her own Private Clinic of Dermatovenereology. Professional orientation: aesthetic dermatology, acne and facial dermatoses, medicinal mycology (nail diseases), wound management, psoriasis, employment of Ichthyol and carboxytherapy in dermatology. She is a coordinator of many international multicentre trials. More than 555 expert lectures in the Slovak Republic as well as abroad, 440 scientific publications. Co-author of the dermatocosmetic formulae containing Ichthamol and glycyrrhizinic acid. Author of the book “Carboxytherapy” (2015), translated into 4 languages. Regularly invited to deliver lectures at international congresses. Founder and President of the Slovak Society for Aesthetic and Cosmetic Dermatology (SSEDK), organizer and President of the traditional international DERMAPARTY congress. Since 2006 Vice-President European Society of Aesthetic and Cosmetic Dermatology, since 2007 President of the European Society of Aesthetic and Cosmetic Dermatology